Startseite Isolation and biochemical characterization of plasma monoclonal free light chains in amyloidosis and multiple myeloma: a pilot study of intact and truncated forms of light chains and their charge properties
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Isolation and biochemical characterization of plasma monoclonal free light chains in amyloidosis and multiple myeloma: a pilot study of intact and truncated forms of light chains and their charge properties

  • Batia Kaplan , Marina Ramirez-Alvarado , Angela Dispenzieri , Steve R. Zeldenrust , Nelson Leung , Avi Livneh und Gloria Gallo
Veröffentlicht/Copyright: 6. Februar 2008
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

Background: The presence of monoclonal immunoglobulin free light chains (FLC) in the serum is commonly associated with the gammopathies, including multiple myeloma, systemic light chain amyloidosis and non-amyloid light chain deposition disease. Although a sensitive nephelometry-based assay is used for quantification of serum FLC and patient follow-up, this method does not provide information regarding the biochemical properties of these proteins. The present study focused on the development of the procedure for isolation and biochemical characterization of monoclonal FLC in small plasma specimens from patients with these disorders.

Methods: Methods used in this study were ultrafiltration, sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), protein elution from gel and support membranes, dialysis, lyophilization, isoelectric focusing (IEF) and Western blotting.

Results: The isolation, concentration and partial purification of FLC was based on micro-preparative SDS-PAGE employing analytical scale gels. For the determination of the isoelectric point of FLC, the developed protocol included consecutive IEF, electrotransfer of IEF-separated proteins onto and elution from support membranes, and their analysis by SDS-PAGE-based Western blotting. The procedures, which require only 20–50 μL of starting plasma, allow biochemical characterization of the monomeric, dimeric and truncated forms of FLC, including their charge properties.

Conclusions: The developed procedure may be applied to reveal distinguishing chemical features of FLC in serum, which could be important in predicting the pathologic form of disease, and in yielding information to better understand the mechanism(s) involved in the deposition of light chains in tissues.

Clin Chem Lab Med 2008;46:335–41.


Corresponding author: Batia Kaplan, PhD, Heller Institute of Medical Research, Sheba Medical Center, Tel-Hashomer 52621, Israel Phone: +972-3-5303363, Fax: +972-3-5356560,

Received: 2007-9-17
Accepted: 2007-10-29
Published Online: 2008-02-6
Published in Print: 2008-03-01

©2008 by Walter de Gruyter Berlin New York

Artikel in diesem Heft

  1. Genetics and Molecular Diagnostics
  2. A rapid and accurate approach to identify single nucleotide polymorphisms of mitochondrial DNA using MALDI-TOF mass spectrometry
  3. An association study of sodium-lithium countertransport activity with glutathione S transferase (GST) T1 and GST M1 null polymorphisms in Greek dyslipidaemic patients and controls
  4. Size distribution of circulating cell-free DNA in sera of breast cancer patients in the course of adjuvant chemotherapy
  5. Suitability of the PAXgene™ system to stabilize bone marrow RNA in imatinib-resistant patients with chronic myeloid leukemia
  6. Genetic polymorphisms of alcohol metabolising enzymes: their role in susceptibility to oesophageal cancer
  7. 5′ ins/del and 3′ VNTR polymorphisms in the apolipoprotein B gene in relation to lipids and coronary artery disease
  8. General Clinical Chemistry and Laboratory Medicine
  9. Isolation and biochemical characterization of plasma monoclonal free light chains in amyloidosis and multiple myeloma: a pilot study of intact and truncated forms of light chains and their charge properties
  10. Simple method for determining human serum 2,2-diphenyl-1-picryl-hydrazyl (DPPH) radical scavenging activity – possible application in clinical studies on dietary antioxidants
  11. Thyroid-related autoantibodies in Tunisian patients with coeliac disease
  12. A dried serum spot assay for vitamin B12
  13. Acute-phase response proteins are related to cachexia and accelerated angiogenesis in gastroesophageal cancers
  14. Vitamin D binding protein, a new nutritional marker in cystic fibrosis patients
  15. Effects of total cholesterol and triglyceride on the percentage difference between the low-density lipoprotein cholesterol concentration measured directly and calculated using the Friedewald formula
  16. Gallstone analysis using Fourier transform infrared spectroscopy (FT-IR)
  17. Coenzyme Q10 and high-sensitivity C-reactive protein in ischemic and idiopathic dilated cardiomyopathy
  18. Increased plasma asymmetric dimethylarginine (ADMA) levels in retinal venous occlusive disease
  19. Effects of extended-release felodipine on endothelial vasoactive substances in patients with essential hypertension
  20. Reference Values
  21. Lithium heparinised blood-collection tubes give falsely low albumin results with an automated bromcresol green method in haemodialysis patients
  22. Infrequency of low red blood cell (RBC) folate levels despite no folate fortification program: a study based on results from routine requests for RBC folate
  23. Validation and Outcome Studies
  24. A new serum cystatin C-based equation for assessing glomerular filtration rate in liver transplantation
  25. Development of des-γ-carboxy prothrombin (DCP) measuring reagent using the LiBASys clinical analyzer
  26. Letters to the Editor
  27. High oxygen-affinity hemoglobin variant associated with high-level venous oxygen saturation
  28. Interference in urinary free cortisol determination by components of the NuvaRing® contraceptive device
  29. The neutral protease chymase degrades apolipoprotein E from high-density lipoproteins
  30. Unclear results in the article by Wolff and Gerritzen in Clin Chem Lab Med 2007;45(7):917–922
  31. Potassium report of hemolyzed serum samples
  32. Reply to the letter by Carraro: appropriate actions in the detection of haemolytic specimens
Heruntergeladen am 7.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2008.068/html?lang=de
Button zum nach oben scrollen